Tailor-made Antibodies
and Tools for Life Science
Home|||||Technical Support

EAAT1 antibody cytoplasmic domain - 250 116

EAATs are transmembrane proteins involved in the removal of extracellular glutamate
Chicken polyclonal IgY fraction
Cat. No.: 250 116
Amount: 200 µl
Price: $360.00
Cat. No. 250 116 200 µl antibody, lyophilized. Albumin and azide was added for stabilization. For reconstitution add 200 µl H2O, then aliquot and store at -20°C until use.
Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
Applications
 
WB: 1 : 1000 up to 1 : 2000 gallery  
ICC: 1 : 500 up to 1 : 1000 gallery  
IHC: 1 : 500 up to 1 : 1000 gallery  
Immunogen Synthetic peptide corresponding to AA 522 to 541 from rat EAAT1 (UniProt Id: P24942)
Reactivity Reacts with: mouse (P56564), rat (P24942).
Other species not tested yet.
Matching control protein/peptide 250-11P
Data sheet 250_116.pdf

References for EAAT1 - 250 116

Inhibiting astrocyte connexin-43 hemichannels blocks radiation-induced vesicular VEGF-A release and blood-brain barrier dysfunction.
Schumacher S, Tahiri H, Ezan P, Rouach N, Witschas K, Leybaert L
Glia (2024) 721: 34-50. 250 116 IHC; tested species: mouse
Cat. No.: 250 116
Amount: 200 µl
Price: $360.00
Inhibiting astrocyte connexin-43 hemichannels blocks radiation-induced vesicular VEGF-A release and blood-brain barrier dysfunction.
Schumacher S, Tahiri H, Ezan P, Rouach N, Witschas K, Leybaert L
Glia (2024) 721: 34-50. 250 116 IHC; tested species: mouse
Background

Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. After the release of glutamate from synaptic vesicles into the synaptic cleft during neurotransmission, excitatory amino acid transporters (EAATs) remove extracellular glutamate to avoid excitotoxic levels (1).
Five EAATs with differential expression patterns have been described so far: EAAT1, also referred to as GLAST and SLC1A3, has neuroprotective potential following ischemia and occurs in reactive astrocytes and activated microglia. EAAT2 (GLT-1, SLC1A2) is the most abundant isoform and is primarily expressed in astrocytes. Both variants show high levels in brain and retina. EAAT3 / SLC1A1, EAAT4 / SLC1A6 and EAAT5 / SLC1A7 are expressed in neurons (2). EAAT4 shows weak expression in the forebrain and high levels in the cerebellum (3). EAAT5 primarily occurs in the retina where it locates very close to glutamate release sites. In K.O. mice flicker resolution is considerably compromised (4). Recent findings suggest that EAAT5 is an abundant isoform, expressed also in non-neuronal peripheral tissues (5).